| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.08B | +3.2% |
| R&D Expense | $175.7M | -1.1% |
| SG&A Expense | $639.4M | +1.5% |
| Operating Income | $561.6M | +4.6% |
| Pre-tax Income | $508.2M | +2.1% |
| Income Tax | $102.1M | +35.4% |
| Net Income | $406.1M | -3.8% |
| EPS (Basic) | $2.77 | +0.4% |
| EPS (Diluted) | $2.76 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $492.2M | +38.1% |
| Accounts Receivable | $527.4M | +0.2% |
| Inventory | $326.5M | -3.3% |
| Current Assets | $1.49B | +8.9% |
| Total Assets | $4.37B | +1.4% |
| Current Liabilities | $1.29B | +41.7% |
| Long-term Debt | $1.59B | -23.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $511.0M | +19.5% |
| Capital Expenditures | $69.9M | -15.5% |
| Investing Cash Flow | -$20.7M | -81.6% |
| Financing Cash Flow | -$371.3M | +5.4% |
| Free Cash Flow | $441.1M | +27.9% |
| +0.4% |
| Total Liabilities |
| $3.12B |
| -4.1% |
| Stockholders' Equity | $1.24B | +18.4% |